title: Urban primary care physicians' perceptions about initiation of controller medications during a pediatric emergency department visit for asthma.
abstract: OBJECTIVE
  This study aimed to identify the beliefs and attitudes of primary care providers (PCPs) regarding emergency department (ED) physicians' initiation of controller medications for children with persistent asthma symptoms during an immediate ED visit.
  
  
  METHODS
  We performed semistructured interviews and a focus group with a purposive sample of PCPs of asthmatic patients to assess attitudes toward the National Asthma and Education Prevention Program recommendations regarding ED-based initiation of controller medications. Interviews and a focus group were digitally recorded, transcribed, and entered into qualitative software for coding and analysis. A multidisciplinary team used content analysis to identify important themes.
  
  
  RESULTS
  A total of 22 pediatricians and 1 nurse practitioner participated, and content saturation was achieved. Of all participants, 57% were from hospital-based practices and 43% were from non-hospital-based practices. All agreed with the new guideline recommendation that emergency medicine physicians should consider initiating controller medications during a short-term visit for asthma. Four major themes were identified: (1) the importance of communication and collaboration between primary care and ED practitioners, (2) patients must meet criteria for inhaled corticosteroids and provide a reliable history, (3) the ED visit offers a lost opportunity for education and may represent a teachable moment, and (4) the ED visit provides a chance to capture patients with frequent exacerbations who are noncompliant with follow-up visits.
  
  
  CONCLUSIONS
  Primary care providers who participated in this study believed that the ED visit offers a valuable opportunity for the initiation of controller medications when ED providers use guideline-based criteria and communicate the intervention to the PCP.
authors.affiliation: The Children's Hospital of Philadelphia and The University of Pennsylvania School of Medicine, Philadelphia, PA, USA. Sampayo@email.chop.edu
authors.forename: Esther Maria
authors.initials: EM
authors.lastname: Sampayo
authors.forename: Joanne
authors.initials: J
authors.lastname: Agnant
authors.forename: Amber
authors.initials: A
authors.lastname: Chew
authors.forename: Joseph
authors.initials: J
authors.lastname: Zorc
authors.forename: Joel
authors.initials: J
authors.lastname: Fein
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001291:Attitude of Health Personnel; D002648:Child; D002675:Child, Preschool; D019468:Disease Management; D004363:Drug Utilization; D004630:Emergencies; D004636:Emergency Service, Hospital; D005260:Female; D017144:Focus Groups; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007223:Infant; D007407:Interviews as Topic; D008297:Male; D010353:Patient Education as Topic; D010372:Pediatrics; D058007:Physicians, Primary Care / Q000523:psychology*; D017410:Practice Guidelines as Topic; D036301:Qualitative Research; D016032:Randomized Controlled Trials as Topic; D014504:Urban Health
chemical_list: D000305:Adrenal Cortex Hormones; D018927:Anti-Asthmatic Agents